Sato, T., Ohara, E., Ozone, C., Okazaki, M., Fuse, S., Sasaki, R., & Azuma, Y. (2021). A Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonist in Kidney Transplant Recipients With Type 2 Diabetes. J Endocr Soc.

Sato, Tetsuhiko, Emi Ohara, Chikafumi Ozone, Mikako Okazaki, Sachiho Fuse, Rie Sasaki, e Yoshinori Azuma. "A Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonist in Kidney Transplant Recipients With Type 2 Diabetes." J Endocr Soc 2021.

Sato, Tetsuhiko, et al. "A Possible Advantage of Glucagon-Like Peptide 1 Receptor Agonist in Kidney Transplant Recipients With Type 2 Diabetes." J Endocr Soc 2021.